Niva Bupa Health Insurance Company Ltd
₹ 73.6
-1.14%
05 Dec
4:01 p.m.
About
Incorporated in 2008, Niva Bupa Health Insurance Ltd is a Tech driven leading health insurer in India.[1]
Key Points
- Market Cap ₹ 13,591 Cr.
- Current Price ₹ 73.6
- High / Low ₹ 99.9 / 61.0
- Stock P/E 147
- Book Value ₹ 20.6
- Dividend Yield 0.00 %
- ROCE 7.45 %
- ROE 8.18 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company has delivered good profit growth of 40.1% CAGR over last 5 years
Cons
- Stock is trading at 3.61 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Tax rate seems low
- Company has a low return on equity of 6.41% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|
| 851 | 1,057 | 1,413 | 1,877 | 2,853 | 4,115 | 5,374 | 5,874 | |
| 880 | 1,094 | 1,435 | 2,328 | 3,183 | 4,228 | 5,296 | 5,793 | |
| Operating Profit | -29 | -37 | -22 | -451 | -330 | -113 | 78 | 81 |
| OPM % | -3% | -3% | -2% | -24% | -12% | -3% | 1% | 1% |
| 0 | 0 | 0 | 281 | 374 | 224 | 160 | 12 | |
| Interest | 3 | 4 | 6 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 16 | 21 | 22 | 27 | 32 | 29 | 25 | 0 |
| Profit before tax | -48 | -62 | -50 | -197 | 13 | 82 | 214 | 93 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | |
| -48 | -62 | -50 | -197 | 13 | 82 | 214 | 93 | |
| EPS in Rs | 1.17 | 0.51 | ||||||
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 38% |
| 3 Years: | 42% |
| TTM: | 23% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 40% |
| 3 Years: | 45% |
| TTM: | -41% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -26% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 1% |
| 3 Years: | 6% |
| Last Year: | 8% |
Balance Sheet
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 981 | 1,126 | 1,350 | 1,409 | 1,511 | 1,700 | 1,827 | 1,846 |
| Reserves | -719 | -780 | -773 | -903 | -683 | 351 | 1,231 | 1,959 |
| 0 | 0 | 0 | 250 | 250 | 250 | 250 | 250 | |
| 737 | 891 | 1,322 | 1,983 | 2,799 | 3,891 | 6,452 | 6,595 | |
| Total Liabilities | 1,000 | 1,237 | 1,899 | 2,738 | 3,877 | 6,192 | 9,760 | 10,650 |
| 30 | 39 | 46 | 49 | 52 | 58 | 66 | 81 | |
| CWIP | 2 | 2 | 2 | 1 | 4 | 1 | 9 | 0 |
| Investments | 816 | 1,067 | 1,622 | 2,401 | 3,366 | 5,458 | 8,175 | 8,482 |
| 152 | 129 | 230 | 287 | 455 | 675 | 1,510 | 2,088 | |
| Total Assets | 1,000 | 1,237 | 1,899 | 2,738 | 3,877 | 6,192 | 9,760 | 10,650 |
Cash Flows
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| 257 | 338 | 593 | 813 | 1,654 | |||
| -374 | -723 | -829 | -1,882 | -2,348 | |||
| 280 | 374 | 280 | 1,110 | 771 | |||
| Net Cash Flow | 164 | -12 | 43 | 41 | 78 |
Ratios
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory Days | |||||||
| Days Payable | |||||||
| Cash Conversion Cycle | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Working Capital Days | -264 | -270 | -290 | -341 | -313 | -298 | -351 |
| ROCE % | -19% | -10% | -30% | 1% | 5% | 7% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
14 Nov - Allotment of 11,11,500 Equity Shares pursuant to ESOP Scheme 2020.
-
Disclosure Under SEBI (LODR) Regulations, 2015
13 Nov - IRDAI approved Nov 12, 2025 acquisition of up to 115,314,606 Niva Bupa shares by DSP entities.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
12 Nov - Niva Bupa to participate in Avendus Spark INDX 2025 investor conference on November 19, 2025.
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
6 Nov - Submission of Transcript of the Earnings call conducted on November 03, 2025.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
6 Nov - Submission of copies of Newspaper publication pertaining to Unaudited Financial Results for the quarter and half year ended September, 2025.
Concalls
-
Nov 2025Transcript PPT REC
-
Aug 2025Transcript PPT
-
May 2025Transcript PPT
-
Feb 2025Transcript PPT REC
-
Nov 2024Transcript PPT
Leading Insurance Company[1] Niva Bupa is the 3rd largest and the 2nd fastest growing standalone health insurer (SAHI) in India based on overall health gross direct premium income (GDPI) of Rs 5,494.43 crore in FY24 with an overall market share of 5.1%.